This Week in JAMA

Premium

In JAMA this week, a team of researchers in Italy presents findings from a study of the effects of triptorelin — a gonadotropin-releasing hormone analog — on the occurrence of chemotherapy-induced early menopause in women with breast cancer. To determine if triptorelin's temporary ovarian suppression effect changed the rate of early menopause during chemotherapy, the team studied 281 premenopausal breast cancer patients and randomly assigned them to receive either chemotherapy alone or with triptorelin.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.